Literature DB >> 32931449

Binder Blunder in CKD.

Joachim H Ix1.   

Abstract

Entities:  

Keywords:  mineral metabolism

Year:  2020        PMID: 32931449      PMCID: PMC7608963          DOI: 10.1681/ASN.2020081182

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  11 in total

1.  Effects of phosphate binders in moderate CKD.

Authors:  Geoffrey A Block; David C Wheeler; Martha S Persky; Bryan Kestenbaum; Markus Ketteler; David M Spiegel; Matthew A Allison; John Asplin; Gerard Smits; Andrew N Hoofnagle; Laura Kooienga; Ravi Thadhani; Michael Mannstadt; Myles Wolf; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2012-07-19       Impact factor: 10.121

2.  Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability.

Authors:  Andrew J King; Matthew Siegel; Ying He; Baoming Nie; Ji Wang; Samantha Koo-McCoy; Natali A Minassian; Qumber Jafri; Deng Pan; Jill Kohler; Padmapriya Kumaraswamy; Kenji Kozuka; Jason G Lewis; Dean Dragoli; David P Rosenbaum; Debbie O'Neill; Allein Plain; Peter J Greasley; Ann-Cathrine Jönsson-Rylander; Daniel Karlsson; Margareta Behrendt; Maria Strömstedt; Tina Ryden-Bergsten; Thomas Knöpfel; Eva M Pastor Arroyo; Nati Hernando; Joanne Marks; Mark Donowitz; Carsten A Wagner; R Todd Alexander; Jeremy S Caldwell
Journal:  Sci Transl Med       Date:  2018-08-29       Impact factor: 17.956

3.  Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial.

Authors:  Joachim H Ix; Tamara Isakova; Brett Larive; Kalani L Raphael; Dominic S Raj; Alfred K Cheung; Stuart M Sprague; Linda F Fried; Jennifer J Gassman; John P Middleton; Michael F Flessner; Geoffrey A Block; Myles Wolf
Journal:  J Am Soc Nephrol       Date:  2019-05-13       Impact factor: 10.121

4.  A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD.

Authors:  Geoffrey A Block; Martha S Block; Gerard Smits; Rupal Mehta; Tamara Isakova; Myles Wolf; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2019-07-05       Impact factor: 10.121

Review 5.  A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease.

Authors:  Tamara Isakova; Orlando M Gutiérrez; Myles Wolf
Journal:  Kidney Int       Date:  2009-07-15       Impact factor: 10.612

6.  A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD).

Authors:  Nigel D Toussaint; Eugenia Pedagogos; Nicole M Lioufas; Grahame J Elder; Elaine M Pascoe; Sunil V Badve; Andrea Valks; Geoffrey A Block; Neil Boudville; James D Cameron; Katrina L Campbell; Sylvia S M Chen; Randall J Faull; Stephen G Holt; Dana Jackson; Meg J Jardine; David W Johnson; Peter G Kerr; Kenneth K Lau; Lai-Seong Hooi; Om Narayan; Vlado Perkovic; Kevan R Polkinghorne; Carol A Pollock; Donna Reidlinger; Laura Robison; Edward R Smith; Robert J Walker; Angela Yee Moon Wang; Carmel M Hawley
Journal:  J Am Soc Nephrol       Date:  2020-09-11       Impact factor: 10.121

7.  Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients.

Authors:  Yi-Wen Chiu; Isaac Teitelbaum; Madhukar Misra; Essel Marie de Leon; Tochi Adzize; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 8.237

Review 8.  Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation.

Authors:  Geoffrey A Block; Joachim H Ix; Markus Ketteler; Kevin J Martin; Ravi I Thadhani; Marcello Tonelli; Myles Wolf; Harald Jüppner; Keith Hruska; David C Wheeler
Journal:  Am J Kidney Dis       Date:  2013-06-12       Impact factor: 8.860

9.  Phosphate-Binder Use in US Dialysis Patients: Prevalence, Costs, Evidence, and Policies.

Authors:  Wendy L St Peter; Lori D Wazny; Eric D Weinhandl
Journal:  Am J Kidney Dis       Date:  2017-11-28       Impact factor: 8.860

10.  Relationship of dietary phosphate intake with risk of end-stage renal disease and mortality in chronic kidney disease stages 3-5: The Modification of Diet in Renal Disease Study.

Authors:  Umut Selamet; Hocine Tighiouart; Mark J Sarnak; Gerald Beck; Andrew S Levey; Geoffrey Block; Joachim H Ix
Journal:  Kidney Int       Date:  2016-01-04       Impact factor: 10.612

View more
  2 in total

Review 1.  Inflammation: a putative link between phosphate metabolism and cardiovascular disease.

Authors:  Jakob Voelkl; Daniela Egli-Spichtig; Ioana Alesutan; Carsten A Wagner
Journal:  Clin Sci (Lond)       Date:  2021-01-15       Impact factor: 6.124

Review 2.  Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins.

Authors:  Solène M Laville; Ziad A Massy; Said Kamel; Jean Marc Chillon; Gabriel Choukroun; Sophie Liabeuf
Journal:  Toxins (Basel)       Date:  2021-01-26       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.